ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Muscular dystrophy in dogs reversed with gene therapy–are children next? – Genetic Literacy Project

Continue reading

2017-08-02 Michael Zand NEWS

Spark Therapeutics offers a glimpse of efficacy in first two hemophilia A gene therapy patients – Endpoints News


Genetic Literacy Project

Muscular dystrophy in dogs reversed with gene therapy–are children next?
Genetic Literacy Project
Duchenne muscular dystrophy (DMD) is the most common and, sadly, the most severe form of the debilitating genetic disorder. Now researchers have used a new gene therapy technique to restore muscle strength and stabilize the symptoms of the disorder in …

and more »

Continue reading

2017-08-02 Michael Zand NEWS

Global T-Cell Immunotherapy Pipeline Analysis, 2016 – Clinical Trials & Results, Patent, Designation, Collaboration … – Business Wire (press release)

Global T-Cell Immunotherapy Pipeline Analysis, 2016 – Clinical Trials & Results, Patent, Designation, Collaboration …Business Wire (press release)T-cell immunotherapy mainly consists of T-cell receptor (TCR), Tumor-infiltrating lymphocytes (TILs)… Continue reading

2017-08-02 Michael Zand NEWS

Agilis Biotherapeutics and Gene Therapy Research Institution Enter into Strategic Partnership – Business Wire (press release)

Agilis Biotherapeutics and Gene Therapy Research Institution Enter into Strategic PartnershipBusiness Wire (press release)CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative… Continue reading

2017-08-02 Michael Zand NEWS

Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood … – PR Newswire (press release)


Endpoints News

Spark Therapeutics offers a glimpse of efficacy in first two hemophilia A gene therapy patients
Endpoints News
Noted Jefferies’ Michael Yee recently: “First data from Phase I/II of Hemophilia A gene therapy SPK-8011 in July/Aug could establish early proof-of-concept and be a (+) catalyst. Given small no. of pts to start, key is demonstrating potential to get to …
Spark Therapeutics Inc (ONCE): Showing Signs Of Making It BigSimply Wall St

all 25 news articles »

Continue reading

2017-08-02 Michael Zand NEWS

New Gene Therapy to Fix Dystrophin Deficiency in DMD Shows Promise in Mice, Study Shows – Muscular Dystrophy News

New Gene Therapy to Fix Dystrophin Deficiency in DMD Shows Promise in Mice, Study ShowsMuscular Dystrophy NewsResearchers at the University of Missouri have developed a new method to efficiently deliver the correct form of dystrophin gene to muscles as… Continue reading

2017-08-02 Michael Zand NEWS

Could CRISPR Repair CFTR in Cystic Fibrosis Patients? – News-Medical.net

News-Medical.netCould CRISPR Repair CFTR in Cystic Fibrosis Patients?News-Medical.netCRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats in reference to the repeating DNA sequences found in the genomes of bacteria. They function… Continue reading

2017-08-02 Michael Zand NEWS

Could CRISPR Repair CFTR in Cystic Fibrosis Patients? – News-Medical.net

News-Medical.netCould CRISPR Repair CFTR in Cystic Fibrosis Patients?News-Medical.netCRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats in reference to the repeating DNA sequences found in the genomes of bacteria. They function… Continue reading

2017-08-02 Michael Zand NEWS
  • 1
  • …
  • 1,414
  • 1,415
  • 1,416
  • 1,417
  • 1,418
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood …
PR Newswire (press release)
As the clinical experience and scientific publications continue to grow, we predict that CytoSorbents, through CytoSorb®, will solidify its leadership in critical care and cardiac surgery, with expansion into other promising fields such as cancer …